Skip to content

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06851975
Acronym
BEST
Enrollment
40000
Registered
2025-02-28
Start date
2020-01-07
Completion date
2099-12-31
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Research into biomarkers predictive of survival and response to cancer treatment

Interventions

OTHERblood sampling

36ml of blood will be taken during a blood sampling performed in standard practice

Sponsors

Centre Antoine Lacassagne
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care, * Patient who has read the information note and stated that he/she has no objections * Patient who has not objected to the use of this data for medical research purposes * Patient with social security cover.

Exclusion criteria

* Patient already included in the study * Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8

Design outcomes

Primary

MeasureTime frameDescription
Predictionday 1The aim of this project is to make a biobank in prevision of MR004 sub-projects which define specific biomarkers studied to identify biomarkers predictive of response.

Countries

France

Contacts

CONTACTVictoria FERRARI, Dr
victoria.ferrari@nice.unicancer.fr+33 492031311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026